Founders Capital Management (Texas)’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-133
| Closed | -$1.66K | – | 380 |
|
|
2024
Q3 | $1.66K | Hold |
133
| – | – | ﹤0.01% | 337 |
|
|
2024
Q2 | $1.74K | Hold |
133
| – | – | ﹤0.01% | 333 |
|
|
2024
Q1 | $3.02K | Hold |
133
| – | – | ﹤0.01% | 325 |
|
|
2023
Q4 | $1.73K | Hold |
133
| – | – | ﹤0.01% | 354 |
|
|
2023
Q3 | $2.68K | Hold |
133
| – | – | ﹤0.01% | 362 |
|
|
2023
Q2 | $3.58K | Hold |
133
| – | – | ﹤0.01% | 351 |
|
|
2023
Q1 | $8K | Hold |
133
| – | – | 0.01% | 326 |
|
|
2022
Q4 | $7K | Hold |
133
| – | – | 0.01% | 322 |
|
|
2022
Q3 | $11K | Hold |
133
| – | – | 0.01% | 284 |
|
|
2022
Q2 | $9K | Sell |
133
-67
| -34% | -$4.53K | 0.01% | 321 |
|
|
2022
Q1 | $19K | Hold |
200
| – | – | 0.01% | 217 |
|
|
2021
Q4 | $19K | Hold |
200
| – | – | 0.01% | 217 |
|
|
2021
Q3 | $17K | Buy |
200
+133
| +199% | +$11.3K | 0.01% | 230 |
|
|
2021
Q2 | $10K | Buy |
+67
| New | +$10K | 0.01% | 265 |
|